After the United States wants to secure the European Union with sufficient quantities of the Corona By means of Remdesivir. It will be negotiated with the manufacturer, Gilead Sciences, announced a spokesman for the EU Commission on Thursday. He reiterated at the same time that the medium is expected to be the end of this week for the European market.
Remdesivir is considered to be one of the few effective drugs for severe cases of the Coronavirus-induced lung disease Covid-19. It can be shorten according to studies, the hospital stay. The American government had made an agreement with Gilead announced that it has practically buys the whole production amount of By means of for the next few months. However, for example, Germany has already created inventories of the product.
The EU Commission spokesman said it is negotiating with the manufacturer, a reservation of a sufficient number of treatment doses of the Agent. The negotiations are at an early stage. On the quantity and the cost he wanted to say anything.
